Sponsorship

It's time to STOP Diabetes for good.

SPONSORSHIP

For over 30 years, the Alberta Diabetes Foundation (ADF) has been funding innovative research to change lives for people living with diabetes. Initial investment in clinical trials for islet cell transplantation led to the “Edmonton Protocol” — still an international standard of care. And now, we will work with partners with unwavering commitment to investing in A CURE. No more insulin, no more treating symptoms, no more blood-sugar regulation. It sounds like science fiction, but it’s science — and we’re close to making it a reality.

DEFEATING DIABETES

Defeating Diabetes is a collaborative partnership between ADF, Alberta Diabetes Institute, DRIFCan and the University of Alberta focused on prevention, treatment and cure of diabetes.

INNOVATIONS IN RESEARCH

ADF will catalyze partnerships to rapidly and strategically fund Alberta-based, innovative research with global impact and/or commercial potential.

INVEST WITH ADF

INVEST IN A CURE!

Partnering with ADF is an investment in diabetes research with demonstrated impact and a high return on investment. Your investment can be directed to specific areas of research and/or sponsorship within ADF signature events.

SIGNATURE EVENTS

INNOVATIONS IN RESEARCH RECEPTION: An exclusive research reception that celebrates donors and their

contributions to ADF research. Current and future projects are discussed within the network of World class

researchers and business leaders that recognize the value of investing in research in Alberta for the world.

48 HOURS TO STOP DIABETES: An industry driven 48 hour webathon of interactive engagement, entertainment, contests and pledges to diabetes research. Every hour will offer something unique to donors, customers and viewers. A fantasy game-a-thon and a poker tournament will be added fun.

HALLOWEEN HOWL RUN/WALK: The Halloween Howl hosts families, teams and businesses – to run, walk, or

roll to raise funds for diabetes research. A Halloween themed, Fun for all ages, community event with fundraising

competitions, costumes and prizes. Everyone wins at the Halloween Howl!

WORLD DIABETES MONTH: November is Diabetes Awareness Month and Nov 14 is World Diabetes Day.

Throughout the month we are committed to raising awareness, sharing stories of real-life with diabetes,

spotlighting promising research and recognizing donor contributions.

ADF PARTNERSHIP OPTIONS & BENEFITS

INNOVATORS $25,000+ (Multi Year):

INNOVATORS are provided with presenting partner recognition and unique benefits.

Presenting partners are attached to specific programs, events or activities with defined outcomes, reach and target audience.
Innovators have the opportunity to work with ADF to define objectives, materials, and messaging and will be celebrated in a feature story in ADF e-newsletter, website and through digital and social media.
Exclusive access to engage world-renowned researchers in the lab.
Plus dividends included in all other levels of support.

CHAMPIONS $10,000 (up to):

CHAMPIONS are provided with unique

recognition in specific initiatives and events.

Presenting Sponsor recognition for signature events.
Partners are included in ADF website, media promotions and digital and social media platforms.
Plus dividends included in LEADERS level support.

LEADERS $5,000 (up to):

CHAMPIONS are provided with unique

recognition in specific initiatives and events.

LEADERS are recognized in public

announcements of initiative/project

partnership on digital and social media.

Plus dividends included in FRIENDS

level support.

FRIENDS $1,000 (up to):

FRIENDS are included on project donor list on ADF website and Annual Report.

All ADF Partners receive: Invitations to events, conferences and meetings (AGM); company

name/logo included in Annual Report and other publications as applicable; company name/logo

included in event programs and special event materials as applicable.

Third Party Events: Third party events in support of province wide research would be recognized at similar levels as above. Third Party events will be provided with an individual webpage within ADF website, specific to

their event, for donation collection and sponsor recognition. Please contact ADF for access to a Third Party Event Toolkit to ensure the success of your event.

Sponsorship is vital to the Alberta diabetes Foundation. Sponsors are needed for every fundraising event.

Please contact our Executive Director (ExecutiveDirector@ABDiabetes.com) for sponsorship opportunities.

OUR RESEARCH

The Alberta Diabetes Foundation rapidly and strategically funds cutting edge diabetes research in Alberta, for the world.

Type 1 Diabetes (T1D) is an auto-immune disease in which the body’s own immune cells attack and kill

insulin-producing beta cells. Our bodies depend on insulin to live. Approximately 10% of people with diabetes

are insulin dependent. Diabetes is the leading cause of non-traumatic lower limb amputation in Canadian adults.

According to the Canadian Pediatric Society, 33,000 school age children in Canada have T1D.

Nanomedicines

Tackles Huge Disease

Dr. Pere Santamaria

This University of Calgary-based collaboration will use nanotechnology at a molecular level to reprogram the immune cells that cause the destruction of the insulin-producing beta cells (in an auto-immune attack) into protective immune cells that work to suppress the autoimmune

attack. By stopping the attack, those people with T1D can once again regenerate their own beta cells and produce their own insulin - all without the need for antirejection medication.

A Better Version of the Edmonton Protocol

Dr. Andrew Pepper

One of the major issues with islet transplantation is that close to half of the islets being transplanted are lost within the first few days post-transplant. This means at least two pancreas donors are required for each islet transplantation performed under the Edmonton Protocol. This project will examine one of the mechanisms of islet cell death with the aim of stopping that process. Less islet cell death means less donor pancreases required per transplant which means more people would be able to recieve the transplant.